Shenzhen Huace testing and University of California cooperate to establish clinical medicine laboratory

Source: on April 10, 2014, the board of directors of Regent of University of California system officially approved UCLA health to establish a joint venture with Shenzhen CTI on January 22, 2014 UCLA health and CTI signed a partnership and joint venture agreement on April 8, 2014, with the purpose of establishing and operating the clinical medicine laboratory in Shanghai, China The cooperation will greatly promote China's medical level, clinical trial operation and medical education The joint venture will be named as "Shanghai huazheluda medical laboratory Co., Ltd." (English name is "ctipathology / UCLA health") Mr Xu Shuaijun, President of CTI, said: "Huace decided to build a high-end third-party clinical medicine laboratory more than three years ago, and has negotiated with a number of well-known institutions in the United States in the past three years Three years of hard work and dedication draw a perfect conclusion today UCLA Medical College's comprehensive strength is the No 1 Medical College in the West Bank of the United States and the No 1 hospital in patient satisfaction in the United States for many years Joseph Micheli, a well-known business commentator, commented on UCLA health's excellence in the book "expression for excellence" because it has three elements of Apple's innovation + NASA's safety awareness + Ritz Carlton Hotel's six-star service The main body of this cooperation with CTI is the Department of pathology and clinical laboratory in UCLA health system, which has more than 1200 faculty, graduate students, technical personnel and service personnel Its lineup and strength are the best in the industry, especially in molecular diagnosis It is hoped that the cooperation between CTI and UCLA will make outstanding contributions to the development of medical testing and clinical pathological diagnosis, especially molecular diagnosis, and provide better quality services for patients " Dr J Thomas Rosenthal, chief medical officer of UCLA and director of medical center cooperation, said about the background of the project: "the background of the establishment of the joint venture is that UCLA World Health Service Center is eager to further strengthen the academic promotion in the global scope, and intends to improve the health care level of people in other regions by providing education, research and services." "This kind of cooperation will significantly improve China's medical level," said Dr Scott binder, senior vice chairman of the Department of pathology and Medical Laboratory of David Geffen Medical College Affiliated to UCLA "Due to the long-term cooperation between UCLA Medical Center and the Second Affiliated College of Zhejiang University and the Chinese Academy of Medical Sciences, we have a clear understanding of China's medical and medical development At present, reliable and reproducible tumor testing, especially in the fields of immunohistochemistry, molecular pathology, flow cytometry and cytogenetics, is still in urgent need of further development and improvement in China Dr Scott binder also believes that the joint venture laboratory will create a large number of medical education opportunities The professional training and sincere cooperation of UCLA medical experts on Chinese Pathologists, technical experts, residents and medical students will significantly promote the professional level of Chinese medical examination and pathological diagnosis practitioners About UCLA health service system UCLA health service system has been established for half a century, providing the best and most advanced medical services for Los Angeles and the rest of the world The system consists of Ronald Reagan medical center, Santa Monica medical center, Resnick neuropsychiatric hospital, Mattel children's Hospital and other medical institutions UCLA Medical Group and its widely distributed basic and professional medical service institutions are the most comprehensive and advanced health service delivery system in the world About CTI, CTI is the pioneer and leader of China's largest third-party testing and verification service organization listed on Shenzhen Stock Exchange Headquartered in Shenzhen, China, it has more than 40 branches in mainland China Laboratories, technical experts and auditors all over the country provide important technical and cost advantages for Chinese service brands and manufacturers At the same time, CTI has set up branches in Taiwan, Hong Kong, Singapore, the United Kingdom, Ireland and the United States.